Harr Steve

CIK 00016273873 companiesSEATTLE, WA

SEC Profile

Transactions

Companies

Filings

CIK

0001627387

Recent Transactions

50 trades

Tax Payment
Sana Biotechnology, Inc.$SANA
Common Stock
2025-03-10$2.56/sh−12,820→ 7,876,930 total
Exercise/Conversion
Sana Biotechnology, Inc.$SANA
Common Stock
2025-03-07+50,000→ 7,889,750 total
Exercise/Conversion
Sana Biotechnology, Inc.$SANA
Restricted Stock Units
2025-03-07−50,000→ 150,000 total
Award
Sana Biotechnology, Inc.$SANA
Restricted Stock Units
2025-03-06+166,667→ 166,667 total
Award
Sana Biotechnology, Inc.$SANA
Stock Option (Right to Buy)
2025-03-06+750,000→ 750,000 total
Award
Sana Biotechnology, Inc.$SANA
Stock Option (Right to Buy)
2024-03-07+900,000→ 900,000 total
Award
Sana Biotechnology, Inc.$SANA
Restricted Stock Units
2024-03-07+200,000→ 200,000 total
Award
Sana Biotechnology, Inc.$SANA
Stock Options (Right to Buy)
2023-03-02+650,000→ 650,000 total
Award
Sana Biotechnology, Inc.$SANA
Stock Options (Right to Buy)
2022-03-03+760,000→ 760,000 total
Gift
Sana Biotechnology, Inc.$SANA
Common Stock
2021-04-14−167,000→ 7,839,750 total
Gift
Sana Biotechnology, Inc.$SANA
Common Stock
2021-04-14−167,000→ 8,006,750 total
Conversion
Sana Biotechnology, Inc.$SANA
Series B Convertible Preferred Stock
2021-02-08−156,250→ 0 total
Conversion
Sana Biotechnology, Inc.$SANA
Series A-2 Convertible Preferred Stock
2021-02-08−800,000→ 0 total
Conversion
Sana Biotechnology, Inc.$SANA
Series A-1 Convertible Preferred Stock
2021-02-08−1,075,000→ 0 total
Conversion
Sana Biotechnology, Inc.$SANA
Common Stock
2021-02-08+2,031,250→ 8,173,750 total
Disposition to Issuer
Loxo Oncology, Inc.
Employee Stock Option (Right to Buy)
2019-02-15$235.00/sh−15,625→ 0 total
Disposition to Issuer
Loxo Oncology, Inc.
Employee Stock Option (Right to Buy)
2019-02-15$235.00/sh−8,750→ 0 total
Disposition to Issuer
Loxo Oncology, Inc.
Employee Stock Option (Right to Buy)
2019-02-15$235.00/sh−11,000→ 0 total
Award
Loxo Oncology, Inc.
Director Stock Option (right to buy)
2018-06-13+8,750→ 8,750 total
Disposition to Issuer
Juno Therapeutics, Inc.
Common Stock
2018-03-05$87.00/sh−50,010→ 97,152 total
Disposition to Issuer
Juno Therapeutics, Inc.
Common Stock
2018-03-05−29,135→ 47,437 total
Disposition to Issuer
Juno Therapeutics, Inc.
Common Stock
2018-03-05−11,544→ 35,893 total
Disposition to Issuer
Juno Therapeutics, Inc.
Common Stock
2018-03-05−35,893→ 0 total
Disposition to Issuer
Juno Therapeutics, Inc.
Employee Stock Option (Right to Buy)
2018-03-05−85,000→ 0 total
Disposition to Issuer
Juno Therapeutics, Inc.
Employee Stock Option (Right to Buy)
2018-03-05−98,750→ 0 total
Disposition to Issuer
Juno Therapeutics, Inc.
Employee Stock Option (Right to Buy)
2018-03-05−155,000→ 0 total
Disposition to Issuer
Juno Therapeutics, Inc.
Employee Stock Option (Right to Buy)
2018-03-05−127,841→ 0 total
Disposition from Tender
Juno Therapeutics, Inc.
Common Stock
2018-03-05$87.00/sh−492,355→ 147,162 total
Disposition to Issuer
Juno Therapeutics, Inc.
Common Stock
2018-03-05−20,580→ 76,572 total
Award
Juno Therapeutics, Inc.
Common Stock
2018-02-27+11,544→ 639,517 total
Gift
Juno Therapeutics, Inc.
Common Stock
2018-02-07−162,790→ 627,973 total
Tax Payment
Juno Therapeutics, Inc.
Common Stock
2018-02-07$85.49/sh−1,704→ 790,763 total
Award
Juno Therapeutics, Inc.
Common Stock
2018-01-31+29,135→ 792,467 total
Sale
Juno Therapeutics, Inc.
Common Stock
2017-12-21$44.74/sh−8,250→ 763,832 total
Exercise/Conversion
Juno Therapeutics, Inc.
Stock Option (Right to Buy)
2017-12-21−8,750→ 98,750 total
Exercise/Conversion
Juno Therapeutics, Inc.
Common Stock
2017-12-21$8.72/sh+8,750→ 772,082 total
Sale
Juno Therapeutics, Inc.
Common Stock
2017-12-21$45.18/sh−500→ 763,332 total
Award
Juno Therapeutics, Inc.
Common Stock
2017-10-20+35,893→ 763,332 total
Exercise/Conversion
Juno Therapeutics, Inc.
Stock Option (Right to Buy)
2017-07-03−8,750→ 107,500 total
Exercise/Conversion
Juno Therapeutics, Inc.
Common Stock
2017-07-03$8.72/sh+8,750→ 736,189 total
Sale
Juno Therapeutics, Inc.
Common Stock
2017-07-03$30.00/sh−8,750→ 727,439 total
Exercise/Conversion
Juno Therapeutics, Inc.
Common Stock
2017-06-27$8.72/sh+8,750→ 736,189 total
Sale
Juno Therapeutics, Inc.
Common Stock
2017-06-27$30.00/sh−8,750→ 727,439 total
Exercise/Conversion
Juno Therapeutics, Inc.
Stock Option (Right to Buy)
2017-06-27−8,750→ 116,250 total
Award
Loxo Oncology, Inc.
Director Stock Option (right to buy)
2017-06-22+11,000→ 11,000 total
Award
Juno Therapeutics, Inc.
Stock Option (Right to Buy)
2017-02-07+127,841→ 127,841 total
Award
Juno Therapeutics, Inc.
Common Stock
2017-02-07+27,439→ 727,439 total
Award
Loxo Oncology, Inc.
Director Stock Option (right to buy)
2016-11-07+15,625→ 15,625 total
Sale
Juno Therapeutics, Inc.
Common Stock
2016-06-10$43.69/sh−16,052→ 700,000 total
Sale
Juno Therapeutics, Inc.
Common Stock
2016-06-10$42.88/sh−13,948→ 716,052 total

Companies

Recent Filings

Address

307 WESTLAKE AVENUE NORTH, SUITE 300

SEATTLE, WA, 98109

View on SEC.gov